J Clin Exp Hepatol. 2019 Jan-Feb;9(1):34-42. doi: 10.1016/j.jceh.2018.02.002. Epub 2018 Feb 16.
Hepatitis B Virus Infection of Normal Hepatic Stem/Progenitor Cells.
Journal of clinical and experimental hepatology
Wendy W Bautista, Carla Osiowy, Julianne Klein, Gerald Y Minuk
Affiliations
Affiliations
- Section of Hepatology, Department of Medicine, University of Manitoba, Winnipeg, Canada.
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada.
- Diagnostic Services Manitoba, Department of Pathology, St. Boniface General Hospital, University of Manitoba, Winnipeg, Canada.
PMID: 30765937
PMCID: PMC6363946 DOI: 10.1016/j.jceh.2018.02.002
Abstract
BACKGROUND/AIMS: Whether the hepatitis B virus (HBV) infects normal hepatic stem/progenitor cells (NSCs) and if so, whether such infections play a role in the pathogenesis of HBV-induced chronic liver disease (CLD) and/or hepatocellular carcinoma (HCC) remains to be determined. The objectives of this study were to determine whether HBV infects NSCs and whether such infections alter NSC activity in a manner likely to contribute to the development of CLD and/or HCC.
METHODS: Liver biopsies from five hepatitis B surface antigen (HBsAg) positive patients were co-stained for HBcAg and HBx and the stem cell markers EpCAM, Oct-4 and Nanog. In addition, primary NSCs derived from healthy human livers were exposed to HBV contaminated serum
RESULTS: Markers of HBV infection were present within the NSC population of all five biopsy specimens.
CONCLUSIONS: Although the results of this study need to be confirmed, they suggest that HBV infects human NSCs but in the short term, do not alter those NSC features or activities associated with CLD and/or HCC.
Keywords: IU, international units; Neg, negative; SN, supernatant; UND, undetected; chronic hepatitis B; d, days; hepatic progenitor cells; hepatic stem cells; hepatitis B virus; hepatocellular carcinoma; ml, milliliters
References
- J Hepatol. 1999 Mar;30(3):492-7 - PubMed
- Semin Liver Dis. 1999;19(2):157-69 - PubMed
- Carcinogenesis. 2003 Jul;24(7):1167-76 - PubMed
- J Viral Hepat. 2005 Jul;12(4):364-72 - PubMed
- Gastroenterology. 2005 Jul;129(1):234-45 - PubMed
- Drugs Today (Barc). 2007 Jun;43(6):379-94 - PubMed
- Adv Biochem Eng Biotechnol. 2007;106:41-73 - PubMed
- Cell Biol Int. 2009 Apr;33(4):493-500 - PubMed
- Hepatogastroenterology. 2009 Jul-Aug;56(93):964-7 - PubMed
- Clin Liver Dis. 2010 Nov;14(4):705-18 - PubMed
- World J Hepatol. 2010 Mar 27;2(3):114-26 - PubMed
- Cancer Res. 2011 May 15;71(10):3701-8 - PubMed
- Virol J. 2011 Oct 31;8:486 - PubMed
- Gut. 2012 Dec;61(12):1754-64 - PubMed
- Methods Mol Biol. 2012;826:25-32 - PubMed
- Arch Pharm Res. 2012 Feb;35(2):213-21 - PubMed
- Arch Pharm Res. 2012 Feb;35(2):261-9 - PubMed
- Hepatology. 2013 Jan;57(1):59-69 - PubMed
- J Hepatol. 2013 Oct;59(4):746-52 - PubMed
- Gastroenterology. 2014 Apr;146(4):1070-83 - PubMed
- Can J Physiol Pharmacol. 2014 Jan;92(1):85-91 - PubMed
- Int J Mol Sci. 2014 Apr 10;15(4):6096-110 - PubMed
- Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12193-8 - PubMed
- Cell Immunol. 2014 Nov-Dec;292(1-2):94-101 - PubMed
- Med Hypotheses. 2016 Jun;91:24-27 - PubMed
- Can J Infect Dis Med Microbiol. 2016;2016:8931591 - PubMed
- Am J Physiol. 1987 May;252(5 Pt 1):G642-7 - PubMed
- N Engl J Med. 1997 Dec 11;337(24):1733-45 - PubMed
Publication Types